Blood pressure medication recalled nationwide. See affected drug
Inventia Healthcare Limited is voluntarily recalling thousands of bottles of chlorthalidone blood pressure medication nationwide after the tablets failed standard FDA dissolution testing. The recall affects 25 mg tablets carrying batch number RISA24002 and an expiration date of March 2027. Officials classified the action under the Food and Drug Administration's Class II risk level. Patients taking the blood pressure medication are urged to inspect their prescription bottles to determine if their medication is impacted by the quality issue, which can alter how the drug functions inside the body.
Listen to Live Briefing
Real-time synthesized voice briefing Β· Live Feeds Desk
- β Inventia Healthcare Limited is voluntarily recalling blood pressure medication nationwide.
- β The recalled medication is chlorthalidone.
- β The recall is classified under the FDA's Class II risk level.
- β The recall was triggered because the tablets failed FDA dissolution testing.
What changed
Inventia Healthcare recalled more than 25,000 bottles of chlorthalidone tablets nationwide following failed dissolution tests.
Live updates
-
Nationwide Blood Pressure Medication Recall Issued by FDA
Inventia Healthcare Limited is voluntarily recalling thousands of bottles of chlorthalidone blood pressure medication nationwide after the tablets failed standard FDA dissolution testing. The recall affects 25 mg tablets carrying batch number RISA24002 and an expiration date of March 2027. Officials classified the action under the Food and Drug Administration's Class II risk level. Patients taking the blood pressure medication are urged to inspect their prescription bottles to determine if their medication is impacted by the quality issue, which can alter how the drug functions inside the body.
Why it matters
Dissolution testing ensures that pharmaceutical tablets break down correctly in the body so the active ingredients can be properly absorbed. When medications fail these standards, patients risk receiving suboptimal doses of their treatment, which can lead to poorly managed health conditions. This event marks a regulatory intervention into the supply chain of widely prescribed cardiovascular medications.
What is confirmed
- Inventia Healthcare Limited is voluntarily recalling blood pressure medication nationwide.
- The recalled medication is chlorthalidone.
- The recall is classified under the FDA's Class II risk level.
- The recall was triggered because the tablets failed FDA dissolution testing.
- More than 25,000 bottles of the medication are involved in the recall.
- The affected bottles contain 25 mg tablets with batch number RISA24002 and an expiration date of March 2027.
Still unconfirmed
- The current action represents a second recall of chlorthalidone from the same manufacturer.
What to watch next
- Further statements from Inventia Healthcare detailing the scope of the manufacturing defect
- Additional updates from the FDA regarding affected distribution channels or injury reports
confidence 100%Sources used for this update (19)
- The Hill β Blood pressure medication recalled nationwide under FDAβs Class II risk level
- WUSA9 β Blood pressure medication recalled nationwide after failing FDA dissolution testing
- Good Housekeeping β FDA Announces New Nationwide Blood Pressure Medication Recall
- newsnationnow.com β Blood pressure medication given Class II designation in recall update
- Newsday β Drug company recalls blood pressure medication chlorthalidone
- USA Today β Blood pressure medication recalled nationwide. See affected drug
- News4JAX β Thousands of bottles of blood pressure medication recalled nationwide
- Dallas News β FDA recalls blood pressure medication after quality issue
- Black Doctor β ALERT: Nationwide Recall of Blood Pressure Medication; 13,000+ Bottles
- qz.com β Inventia Healthcare recalls 25,000 bottles of chlorthalidone tablets
- Democrat and Chronicle β Blood pressure medication recalled over dissolution issue. What to know
- www.usatoday.com β Blood pressure medication recalled. See affected product
Community Sentiment: How do you assess this situation?
Voice your perspective Β· Real-time aggregated sentiment from the Live Feeds community